Companies · Other Health Care

CodaMetrix Inc.

BOSTON · Other Health Care

Diligence memoA one-page analyst read on CodaMetrix Inc. — recommendation, valuation, rhythm, risks.
$106.0M
Total raised · real
3
Rounds
0.3×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Wed Apr 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

CodaMetrix Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.34× the median modeled value of Series C Other Health Care companies in 2025–2027 (20 peers) — value vs value, same stage and era.
Active
  • Last raise 14 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

CodaMetrix Inc. is one of 5376 Other Health Care companies tracked from BOSTON. By capital raised it ranks among the largest (ahead of 96% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2021
Year incorporated
2025-04-16
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries C · 2022-12-16 Raised $57M (real) Modeled valuation $697M (est)$57M$697MSeries C2022Series C · 2024-02-29 Raised $37M (real) Modeled valuation $330M (est)$37M$330MSeries C2024Series C · 2025-04-16 Raised $12M (real) Modeled valuation $78M (est)$12M$78MSeries C2025+$37M+$12MCumulative $106M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$57.4M · 2022
Series C extension$37.0M · 2024
Series C extension$11.6M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$77.7M
Base estimate est.
$42.3M
Conservative case
$105.8M
Upside case
$77.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series C · modeled $697.1M · 2022-12-162022Series C · modeled $329.7M · 2024-02-29Series C · modeled $77.7M · 2025-04-162025
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
1.2 yr
Elapsed time used
1.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
14 mo
Avg between rounds
$45.5M/yr
Capital velocity
3.5 yr
On record since
2022
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 44× above median
This company$106.0M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.3× of median
This company$11.6M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 3.5× above median
This company$77.7M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 74% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #15 of 20.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)RESTOR3D, Inc. · Series C Raised $239.2M · modeled $522.0M (est)ByHeart, Inc. · Series C Raised $378.4M · modeled $493.2M (est)SpyGlassPharma, Inc. · Series C Raised $134.8M · modeled $484.8M (est)VantAI Holdings, Inc. · Series C Raised $86.3M · modeled $475.3M (est)BioIntelliSense, Inc. · Series C Raised $140.0M · modeled $328.7M (est)ObjectiveHealth, Inc. · Series C Raised $68.0M · modeled $321.0M (est)VentureMed Group, Inc. · Series C Raised $59.8M · modeled $288.0M (est)Exo Imaging, Inc. · Series C Raised $169.6M · modeled $284.4M (est)InspireMD, Inc. · Series C Raised $117.2M · modeled $248.1M (est)Fonar, Llc · Series C Raised $51.2M · modeled $228.9M (est)MicroTransponder, Inc. · Series C Raised $117.7M · modeled $223.2M (est)Fourth Edge LLC · Series C Raised $119.7M · modeled $221.8M (est)CodaMetrix Inc. (this company) Raised $106.0M · modeled $77.7M (est)CodaMetrix Inc.
CompanyStageRaised · realValue · estvs peer med.
RESTOR3D, Inc.Series C$239.2M$522.0M2.31×
ByHeart, Inc.Series C$378.4M$493.2M2.18×
SpyGlassPharma, Inc.Series C$134.8M$484.8M2.14×
VantAI Holdings, Inc.Series C$86.3M$475.3M2.10×
BioIntelliSense, Inc.Series C$140.0M$328.7M1.45×
ObjectiveHealth, Inc.Series C$68.0M$321.0M1.42×
VentureMed Group, Inc.Series C$59.8M$288.0M1.27×
Exo Imaging, Inc.Series C$169.6M$284.4M1.26×
InspireMD, Inc.Series C$117.2M$248.1M1.10×
Fonar, LlcSeries C$51.2M$228.9M1.01×
MicroTransponder, Inc.Series C$117.7M$223.2M0.99×
Fourth Edge LLCSeries C$119.7M$221.8M0.98×
CodaMetrix Inc. this companySeries C$106.0M$77.7M0.34×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$57.4M2022-12-16$382.6M$697.1M90%
Series C$37.0M2024-02-29$246.6M$329.7M90%
Series C$11.6M2025-04-16$77.7M$77.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$57.4M2022-12-16
    • First recorded raise — entered as Series C.
    • 12 investors on this round.
  2. Series C$37.0M2024-02-29
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 10 investors on this round.
  3. Series C$11.6M2025-04-16
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 3.2× smaller than the prior — bridge or down round.
    • 7 investors on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~14mo cadence
$11.6M
Modeled next size est.range $11.6M$18.6M
0.3×
Last step-up
$45.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Roger Kitterman4 other2025-04
Keith Kerman3 other2022-12
Christopher Scoggins2 other2022-12
Hamid Tabatabaie2 other2022-12
Mark Pottle2 other2022-12
Todd Cozzens2 other2024-02
Akhilesh Samant2025-04
Gaye Bok2022-12
Jay Aslam2022-12
Jim Whelan2022-12
Kevin Schmitt2022-12
Peter Markell2022-12
Tara Bradley2022-12
Registry & provenance

CodaMetrix Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1959785
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
InfoBionic, Inc.Other Health CareSeries C$103.8M$573.3Mnetwork1 shared operator · same sector · same stage
ECP Manco, LLCOther Health CareSeries C$105.1M$78.3Msame sector · same stage
ReShape Lifesciences Inc.Other Health CareSeries C$113.8M$63.9Msame sector · same stage
Active Implants LLCOther Health CareSeries C$131.9M$84.2Msame sector · same stage
Gaia Herbs IncOther Health CareSeries C$67.9M$68.1Msame sector · same stage
Cleveland HeartLab, Inc.Other Health CareSeries B$35.8M$61.0Mnetwork1 shared operator · same sector
CRES Holdings, Inc.Other Health CareSeries C$61.1M$66.9Msame sector · same stage
Novasys Medical IncOther Health CareSeries C$49.4M$90.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Orametrix IncOther Health CareSeries A$41.7M91%
CODAN US CorpOther Health CareSeries B$144.1M87%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M84%
MorphImmune Inc.Other Health CareSeries B$139.6M83%
Code Biotherapeutics, Inc.Other Health CareSeries B$465.5M83%
Apnomed, Inc.Other Health CarePre-Seed$2.7M83%
Genomedx Inc.Other Health CareSeries B$176.3M83%
MetaModix, Inc.Other Health CareSeed$4.2M83%
Frequently asked
How much funding has CodaMetrix Inc. raised?
CodaMetrix Inc. has raised approximately $106.0M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is CodaMetrix Inc.'s estimated valuation?
Provath's modeled valuation for CodaMetrix Inc. is approximately $77.7M (modeled range $42.3M–$105.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is CodaMetrix Inc. at?
CodaMetrix Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Apr 16.
What does CodaMetrix Inc. do and where is it based?
CodaMetrix Inc. operates in the Other Health Care sector, based in BOSTON.
Explore related

See where CodaMetrix Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at CodaMetrix Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.